Kanter Stacy J.
Transaction: 02/03/2026
SELL
Change
-16,500
Price
$1.05
Filing
02/04/2026
Type
SELL
Applied Therapeutics, Inc.
APLT • Biotechnology
$0.10
— 0.00 (0.00%)
EarningsLatest report: Sep 30, 2025
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$14.99M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.05Healthy liquidity · 3.06Negative growth trendWeak profitability
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Nov 13, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.10
Change0.00%
Shares Out145.56M
Market Cap$14.99M
Enterprise Value$3.05M
52W Range0.09 - 1.50
Beta2.08
P/E-0.83
P/S14.99
P/B-26.72
P/FCF-0.17
EV/Sales3.05
Price$0.10
Change0.00%
Shares Out145.56M
Market Cap$14.99M
Enterprise Value$3.05M
52W Range0.09 - 1.50
Beta2.08
P/E-0.83
P/S14.99
P/B-26.72
P/FCF-0.17
EV/Sales3.05
EV/EBITDA-0.03
EV/FCF-0.04
Earnings Yield-120.98%
FCF Yield-579.26%
Dividend Yield0.00%
Gross Margin-106.13%
Oper. Margin-229.23%
Profit Margin-232.14%
Debt/Eq0.05
Current Ratio3.06
Quick Ratio3.06
Target$2.13
Target Upside1967.96%
Target Median$2.13
Target Range0.25 - 4.00
Volume2.69M
Avg Volume15.80M
EPS Surprise0.01
Investment DNA
How strong this company looks for long-term investors
35
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
53/100
Why this score▼
Manageable debt level · 0.05Healthy liquidity · 3.06Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 11 analyst votes · 2026-09-05
68/100
Neutral
Bullish
5
Hold
5
Bearish
1
Price Target
2026-06-06
Low
$0.25
Mean
$0.25
Median
$0.25
High
$0.25
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Kanter Stacy J.
Transaction: 02/03/2026
SELL
Change
-42,500
Price
$0.09
Filing
02/04/2026
Type
SELL
Lerner Teena
Transaction: 02/03/2026
SELL
Change
-23,941
Price
$4.70
Filing
02/03/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Kanter Stacy J. | SELL | -16,500 | $1.05 | 02/03/2026 | 02/04/2026 |
| Kanter Stacy J. | SELL | -42,500 | $0.09 | 02/03/2026 | 02/04/2026 |
| Lerner Teena | SELL | -23,941 | $4.70 | 02/03/2026 | 02/03/2026 |
| Lerner Teena | SELL | -82,922 | $0.09 | 02/03/2026 | 02/03/2026 |
| Bailey Evan Prescott | SELL | -4,883 | $1.05 | 02/03/2026 | 02/03/2026 |
| Bailey Evan Prescott | SELL | -60,901 | Not reported | 02/03/2026 | 02/03/2026 |
| Funtleyder Leslie D. | SELL | -16,500 | $1.05 | 02/03/2026 | 02/03/2026 |
| Funtleyder Leslie D. | SELL | -152,959 | Not reported | 02/03/2026 | 02/03/2026 |
| SKYLER JAY S | SELL | -16,500 | $1.05 | 02/03/2026 | 02/03/2026 |
| SKYLER JAY S | SELL | -42,500 | $0.09 | 02/03/2026 | 02/03/2026 |
| Chinoporos Constantine | SELL | -57,111 | Not reported | 02/03/2026 | 02/03/2026 |
| Hooks Corwin Dale | SELL | -5,753 | Not reported | 02/03/2026 | 02/03/2026 |
| Bailey Evan Prescott | BUY | +437,500 | Not reported | 12/19/2025 | 02/03/2026 |
| Funtleyder Leslie D. | BUY | +1,187,500 | Not reported | 12/19/2025 | 02/03/2026 |
| Chinoporos Constantine | BUY | +437,500 | Not reported | 12/19/2025 | 02/03/2026 |
| Hooks Corwin Dale | BUY | +312,500 | Not reported | 12/19/2025 | 02/03/2026 |
| Funtleyder Leslie D. | BUY | +150,000 | Not reported | 01/01/2026 | 01/02/2026 |
| Kanter Stacy J. | SELL | -43,000 | $0.11 | 12/16/2025 | 12/18/2025 |
| Funtleyder Leslie D. | BUY | +150,000 | Not reported | 10/01/2025 | 10/01/2025 |
| Funtleyder Leslie D. | BUY | +150,000 | Not reported | 07/01/2025 | 07/03/2025 |